Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on: September 27,2024

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on:September 27,2024

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

Updated on: December 01,2024

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

Updated on:December 01,2024

Researchers propose a navigation system to tackle medication supply bottlenecks

by Christoph Elhardt,ETH ZurichWholesalers can ease supply bottlenecks by rerouting remainder stocks of medications in short supply. Credit: ETH ZurichSupply bottlenecks for medications present

Updated on: May 06,2024

Researchers propose a navigation system to tackle medication supply bottlenecks

by Christoph Elhardt,ETH ZurichWholesalers can ease supply bottlenecks by rerouting remainder stocks of medications in short supply. Credit: ETH ZurichSupply bottlenecks for medications present

Updated on:May 06,2024

AI better than human eye at predicting brain metastasis outcomes, find researchers

by York UniversityArchitecture of (a) vanilla 3D residual network (baseline), (b) the 3D residual network with CBAM attention, (c) the proposed self-attention-guided 3D residual network, (d) the

Updated on: February 20,2024

AI better than human eye at predicting brain metastasis outcomes, find researchers

by York UniversityArchitecture of (a) vanilla 3D residual network (baseline), (b) the 3D residual network with CBAM attention, (c) the proposed self-attention-guided 3D residual network, (d) the

Updated on:February 20,2024

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on: April 06,2024

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on:April 06,2024

European cancer epidemic could occur in next decade if health system weaknesses, cancer research not urgently addressed

byLancetKey findings of The Lancet Oncology Groundshot Commission. Credit: The LancetThe COVID-19 pandemic has exposed weaknesses in cancer health systems and in the cancer research landscape ac

Updated on: January 02,2024

European cancer epidemic could occur in next decade if health system weaknesses, cancer research not urgently addressed

byLancetKey findings of The Lancet Oncology Groundshot Commission. Credit: The LancetThe COVID-19 pandemic has exposed weaknesses in cancer health systems and in the cancer research landscape ac

Updated on:January 02,2024

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache

Updated on: April 28,2024

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache

Updated on:April 28,2024

Growth in plant-based foods industry is slowing: Where does it go from here?

by Brooks Johnson, Star TribuneCredit: Unsplash/CC0 Public DomainWhen Willa's Oat Milk launched five years ago, the plant-based market was rapidly expanding, attracting unprecedented attention and

Updated on: April 10,2024

Growth in plant-based foods industry is slowing: Where does it go from here?

by Brooks Johnson, Star TribuneCredit: Unsplash/CC0 Public DomainWhen Willa's Oat Milk launched five years ago, the plant-based market was rapidly expanding, attracting unprecedented attention and

Updated on:April 10,2024

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are

Updated on: January 12,2024

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are

Updated on:January 12,2024

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre

Updated on: April 29,2024

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre

Updated on:April 29,2024

Using low-intensity continuous ultrasound to inhibit cancer cell migration

by Spanish National Research Council (CSIC)PANC-1 pancreatic cancer cells during a cell migration process. Credit: ITEFI-CSICA study led by Consejo Superior de Investigaciones Científicas (CSIC) has d

Updated on: December 28,2023

Using low-intensity continuous ultrasound to inhibit cancer cell migration

by Spanish National Research Council (CSIC)PANC-1 pancreatic cancer cells during a cell migration process. Credit: ITEFI-CSICA study led by Consejo Superior de Investigaciones Científicas (CSIC) has d

Updated on:December 28,2023

Research concentrates on genes that cause tumors in the Meibomian gland

byTufts UniversityDr. Cornelia Peterson calibrates a piece of equipment used to measure intraocular pressure during an ocular toxicity study in animals. Credit: Noah MossDr. Cornelia Peterson is

Updated on: December 01,2024

Research concentrates on genes that cause tumors in the Meibomian gland

byTufts UniversityDr. Cornelia Peterson calibrates a piece of equipment used to measure intraocular pressure during an ocular toxicity study in animals. Credit: Noah MossDr. Cornelia Peterson is

Updated on:December 01,2024